Sterling Powergensys Ltd.
Sterling Powergensys
₹ 0.00
0.00 (0.00)%
NSE
BSE
Capital Goods
Small-cap - With a market cap of ₹18.05 Cr.
| EX-Date | Purpose |
|---|---|
| 29 06 2021 | Audited Results & A.G.M. |
| 14 08 2021 | Quarterly Results |
| 25 08 2021 | A.G.M. Inter alia, to consider and approve : 1. To appoint Practicing Company Secretaries as the Secretarial Auditors of the Company for the Financial Year 2021-22. 2. To approve sale of undertaking under Section 180(1)(a) of the Companies Act, 2013. 3. To finalize the date, time and venue for convening Annual General Meeting of the Company. |
| 11 11 2021 | Quarterly Results & Inter alia, to consider and approve To consider & approve the following matters 1. Approval of the unaudited financial results along with limited review report of the Company for the period ended 30th September, 2021. 2. To propose commencement of Global Trade of commodities with a view of expansion of the business of the company. 3. To consider & approve Shifting of Registered Office of the Company within local limits. 4. To consider & approve the Sale of property/ undertaking of the Company situated at 2/10, Meghal Service Industrial Estate, Devidayal Road, Mulund West, Mumbai?400080. |
| 04 01 2022 | Inter alia, to consider & approve the following matters : 1. To consider the Appointment of Mr. Shankar Ramnath Iyer as Additional Independent Director (Non-Executive, Independent) to hold office till the conclusion of the ensuing General Meeting and subject to the approval of the shareholders at the ensuing General Meeting. |
| 12 02 2022 | Quarterly Results |
| 24 02 2022 | Inter alia, to consider &approve the following matters: 1. Considering the proposal for Alterarion of Object Clause oI the Memorandum of Association of the Company, subject to the approval of the members of rhe company. 2. To consider the regularisation of Mr. Shankar Ramnath Iyer as Director (NonExecutive, Independent) of the Company subject to the approval oi rhe members of the company. 3. To authorize the Audit Comrnittee to frame Omnibus criteria for approving the related parry transactions for the Financial Year 2022-23. 4, To evaluate rhe performance of the Board, 5, To evaluate tlre perforrnance olevery individual Directors of the Company. 6. To evaluate the performance oFthe committees of theBoard. 7. To evaluate the performance of Independent Directors of the company. 8. To review the Insider Trading policy of the Company |
| 30 05 2022 | Quarterly Results & Audited Results |
| 14 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 04 02 2023 | Quarterly Results |
| 25 03 2023 | Inter-alia, to transact the following agenda items: 1. To authorize Audit Committee to frame omnibus criteria for approving the related party transactions for the financial year 2023-24. 2. To evaluate the performance of the Board. 3. To evaluate the performance of Directors of the Company. 4. To evaluate the performance of the Committees of the Board. 5. To evaluate the performance of Independent Directors of the Company. 6. To review the Insider Trading Policy of the Company |
| 17 05 2023 | A.G.M. & Audited Results |
| 14 08 2023 | Quarterly Results |
| 13 11 2023 | Quarterly Results |
| 10 02 2024 | Quarterly Results |
| 29 03 2024 | Inter alia, to consider and approve:- 1. Noting of resignation by Mr. Yash Dharmendra Sanghvi (DIN: 06934650) from the position of Director of the Company w.e.f. 28th March, 2024. 2. Approval for the reassignment of lease of Property/Undertaking of the Company. |
| 14 11 2024 | Quarterly Results & Preferential Issue of shares |
| 13 02 2025 | Quarterly Results |
| 30 05 2025 | Quarterly Results & Audited Results |
| 14 08 2025 | Quarterly Results |
| 04 09 2025 | A.G.M. |
| 14 11 2025 | Quarterly Results |
| 14 03 2026 | Inter alia, to consider & approve the following matters: 1. To Consider and Approve Re-Appointment of Mr. Sankaran Venkata Subramanian as Managing Director of the Company. 2. Any other matter with the permission of chair and majority of directors present at themeeting. |
| 06 04 2026 | Quarterly Results |
No News data available
